A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant

Scandinavian Journal of Infectious Diseases

Volumn 45, Issue 6, 2013, Pages 494-496

  Antonen, Jaakko ^a   Leppänen, Ilona ^a   Tenhunen, Jyrki ^a,b   Arvola, Pertti ^a   Mäkelä, Satu ^a   Vaheri, Antti ^c   Mustonen, Jukka ^a,d  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Bradykinin; Capillary leakage; Hantavirus; Icatibant

Indexed keywords

CEFTRIAXONE; CORTICOSTEROID; ICATIBANT; NITRIC OXIDE; NORADRENALIN; VASOPRESSIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CAPILLARY LEAK SYNDROME; CASE REPORT; CONTINUOUS RENAL REPLACEMENT THERAPY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DIURESIS; FEVER; FLUID THERAPY; GENERAL CONDITION DETERIORATION; HANTAVIRUS INFECTION; HEADACHE; HEMATURIA; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LEUKOCYTOSIS; LUNG INFILTRATE; MALE; PERITONEAL CAVITY; PLEURA EFFUSION; POLYURIA; PROTEINURIA; PUUMALA VIRUS; RADIOGRAPHY; RESPIRATORY FAILURE; SHOCK; SINGLE DRUG DOSE; THROMBOCYTOPENIA; TREATMENT DURATION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRADYKININ; CAPILLARY LEAK SYNDROME; HANTAVIRUS INFECTIONS; HUMANS; MALE; RECEPTORS, BRADYKININ;

EID: 84877880800     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.755268     Document Type: Article

References (15)

1. Krü ger D H, S ch ön rich G, K lempa B. Human pathogenic hantaviruses and prevention of infection. Hum Vaccin 2011; 7: 685-93.
2. Gosgriff T M. M echanism of disease in hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 1991; 13: 97-107.
3. Maurer M, B ader M, B as M, B ossi F, C icardi M, C ugno M, et al. New topics in bradykinin research. Allergy 2011; 66: 1397-406.
4. Vapalahti O, M ustonen J, L undkvist A, H enttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis 2003; 3: 653-61.
5. Makary P, K anerva M, O llgren J, V irtanen MJ, V apalahti O, Lyytik ä inen O. Disease burden of Puumala virus infections. Epidemiol Infect 2010; 138: 1484-92.
6. Hjertqvist M, Klein SL, Ahlm C, Klingströ m J. Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis 2010; 16: 1584-6.
7. Gavrilovskaya I, Gorbunova E, Matthys V, Dalrymple N, Mackow E. The role of the endothelium in HPS pathogenesis and potential therapeutic approaches. Adv Virol 2012 ; 2012: 467059.
8. Terajima M, H ayasaka D, M aeda K, E nnis F A. I mmunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: do CD8 - T cells trigger capillary leakage in viral hemorrhagic fevers? Immunol Lett 2007; 113: 117-20.
9. Linderholm M, A hlm C, S ettergren B, W aage A, T ä rnvik A. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996; 173: 38-43.
10. M ä kel ä S, M ustonen J, A la-Houhala I, H urme M, K oivisto AM, Vaheri A, et al. Urinary exretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis 2004 ; 43: 809-16.
11. Sane J, L aine O, M äk el ä S, P aakkala A, J arva H, M ustonen J, et al. Complement activation in Puumala hantavirus infection correlates with disease severity. Ann Med 2012; 44: 468-75.
12. Mehta D, M alik AB. S ignalling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86: 279-367.
13. Cockcroft JR, C howwienczyk PJ, B rett SE, B ender N, R itter JM. Inhibition of bradykinin-induced vasodilatation in human forearm vasculature by icatibant, a potent B2- receptor antagonist. Br J Clin Pharmacol 1994; 38: 317-21.
14. Cicardi M, B anjeri A, B racho F, Malbrá n A, Rosenkranz B, Riedl M, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010; 363: 532-41.
15. Deeks E D. I catibant. D rugs 2 010; 7 0: 7 3- 81.